Industry News

In this weeks oncology round-up, we’ve gathered information on the role of long non-coding RNAs in the development of pancreatic cancer, insight into a gene signature in localized prostate cancer, and new applications of cells in cancer therapies.

In addition to the huge news of an FDA approval of the first treatment for COVID-19 (Gilead Science’s antiviral IV drug remdesivir), we’re looking at the FDA approval of the first treatment for Ebola, as well as a novel microneedle-based skin patch.

What’s new in oncology for October 2020? We’ve rounded up information on potential cancer-reducing drugs, liquid biopsy to detect brain tumors, and new immune-like characteristics of cells.

In addition to continued progress and information regarding the ongoing COVID-19 pandemic, October brings forth information on predicting this seasons influenza strain, the body’s response to viral infection, and a potential rotavirus cure.

Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and treatment of the virus. Explore PharPoint’s news roundup and learn more about our extensive infectious disease experience.